- Ulcerative Colitis news are updated once a hour
- We deliver news from more than 500 sources on ulcerative colitis
NewsAdvertisers: |
Sixth-grader ready to raise money to battle her illness...
Maryville Daily Forum: News Column
Sixth-grader ready to raise money to battle her illnessBy CONNIE GOFFconnie_bj@hotmail.comForum ReporterHailey Roush, a sixth-grade student at Maryville Middle School, appears to be a very active 12-year-old girl.She participates in many activities, including basketball and softball. Looks can be deceiving. In December 2003, Hailey was diagnosed with and 2-3 p.m. — at Bearcat Lanes. All proceeds from the bowl-a-thon will go toward research done by the foundation."Hailey is very active in raising money for CCFA," said Hailey's mother, Marcy Roush. "She realizes that she has to live with this condition on a day-to-day basis. She decided to become pro-active instead of inactive. She gets a lot of support from her friends, family and the entire community."Because the foundation provides knowledge from research that can possibly help Hailey's condition, she wants to raise as much money as she can for the organization.Roush participated in the "Heel to Heal" 5K Walk/Run in Kansas City, Mo., last year. She served as emcee for the event along with Valisca Smith of Kansas City's Channel 5 News.“The more we learn about UC and Crohn’s, the more we learn to live with the disease and make it a way of life and not a burden to Hailey... AGI Therapeutics reports drug trials... AGI said it believes that its AGI-022 drug may offer certain advantages compared with currently marketed therapies, including; a superior tolerability profile, a more reliable and targeted delivery to the affected sites in
Source: Businessworld.ie, March 29
Email to author
Article Id: 193768Release date: 29 Mar 2006
About this section
,
Login
Email
Password
forgotten your password?
Shortcuts
A... BioBalance to initiate pouchitis study... The phase I/II multi-center study will be conducted in approximately 63 antibiotic-dependent pouchitis patients to demonstrate the ability of a prescription formulation of Probactrix to maintain symptomatic response of pouchitis symptoms after antibiotic withdrawal compared to placebo. Probactrix is a patented, single strain of non-pathogenic E.coli M-17 that was originally isolated from the intestinal microflora of a healthy volunteer. One mechanism of action is believed to work by selective displacement of pathogenic bacteria in the digestive tract and preventing their re-colonization, restoring a healthy balance of intestinal flora without the potential negative consequences of antibiotic use. The active ingredient in Probactrix has a long history of use for a variety of gastrointestinal conditions, which has been well documented in foreign studies. "We continue to make tremendous strides in advancing the science behind Probactrix and validating the extensive overseas clinical history of this product," said Dennis O'Donnell, BioBalance's president & CEO. RELATED NEWS No Related News COMPANIES MENTIONED No companies found YOUR OPINION... Comment on this Article back to top BUSINESS REVIEW SITES: Food Auto ©2006 Business Review... 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news |
| Health and Fitness | Health Living |